Within 70 TNBC breast tumors, additional authors found that human epidermal growth factor receptor 2-positive (HER2+) patients with predominantly metaplastic cancers exhibited decreased expression of the miR-200 cluster compared to those with oestrogen receptor-positive (ER+) tumors. The gene discussed is ERBB2; the disease is cancer.